Late-breaker poster presentation at the inaugural AACR IO underscores potential of VCR-036, a novel PD-1/CTLA-4 VHH antibody for treatment of solid tumors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback